ProfileGDS5822 / ILMN_2669321
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 11% 15% 29% 2% 19% 32% 12% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 110.311
GSM1276600PDAC Late Ablation Control 213.515
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.429
GSM1276603PDAC Late Ablation 242
GSM1276604PDAC Late Ablation 311.719
GSM1303940PDAC Late Ablation_anti-CTLA4 11632
GSM1303941PDAC Late Ablation_anti-CTLA4 27.912
GSM1303942PDAC Late Ablation_anti-CTLA4 39.818